ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "Nephritis and systemic lupus erythematosus (SLE)"

  • Abstract Number: 641 • 2014 ACR/ARHP Annual Meeting

    Peptidylarginine Deiminase Inhibition Mitigates NET Formation and Protects Against Kidney, Skin, and Vascular Disease in Lupus-Prone MRL/Lpr Mice

    Jason S. Knight1, Venkataraman Subramanian2, Alexander A. O'Dell1, Srilakshmi Yalavarthi1, Wenpu Zhao3, Carolyne K. Smith3, Jeffrey B. Hodgin4, Paul Thompson2 and Mariana J. Kaplan3, 1Department of Internal Medicine, Division of Rheumatology, University of Michigan, Ann Arbor, MI, 2The Scripps Research Institute, Jupiter, FL, 3Systemic Autoimmunity Branch, Intramural Research Program, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 4Department of Pathology, University of Michigan, Ann Arbor, MI

    Background/Purpose:  An imbalance between neutrophil extracellular trap (NET) production and NET degradation has been observed in systemic lupus erythematosus (SLE), potentially contributing to autoantigen externalization,…
  • Abstract Number: 2898 • 2013 ACR/ARHP Annual Meeting

    Atherosclerosis In Systemic Lupus Erythematosus (SLE) and Controls, -An Analysis Of SLE Subgroups

    Johanna Gustafsson1, Kerstin Jensen-Urstad2, Marie Herlitz-Lindberg2, Sonia Möller1, Susanne Pettersson1, Iva Gunnarsson1, Anders Larsson3 and Elisabet Svenungsson4, 1Department of Medicine, Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden, 2Department of Clinical Physiology, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden, 3Department of Clinical Chemistry and Pharmacology, Akademiska Hospital, Uppsala, Sweden, 4Department of Medicine, Unit of Rheumatology, Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: Atherosclerosis is often assumed to be the main underlying cause of premature vascular events (VE) among patients with systemic lupus erythematosus (SLE) and accelerated…
  • Abstract Number: 602 • 2013 ACR/ARHP Annual Meeting

    Repeat Biopsy In Lupus Nephritis: A Single-Center Experience

    Josefina Marin1, Marina Scolnik2, Eliana Lancioni3, Gustavo Greloni4, Cristian Quiroz5, Johana Zacariaz3, Carla Saucedo6, Luis J. Catoggio2 and Enrique R. Soriano2, 1Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 2Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano de Buenos Aires, and Fundacion PM Catoggio, Buenos Aires, Argentina, 3Rheumatology Unit, Internal Medicine Services, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 4Nephrology Service. Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 5Internal Medicine, Rheumatology Unit, Internal Medical Services, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 6Rheumatology Unit, Internal Medical Services, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina

    Background/Purpose: Renal involvement in systemic lupus erythematosus (SLE) is an important cause of morbidity and even mortality. Lupus nephritis has diverse morphologic manifestations with varying clinical…
  • Abstract Number: 608 • 2012 ACR/ARHP Annual Meeting

    Association of Discoid Lupus with Other Clinical Manifestations Among Patients with Systemic Lupus Erythematosus

    Joseph F. Merola1, Christina Iversen2, Jose A. Gomez-Puerta2, Tabatha Norton2, Hsun Tsao2, Peter H. Schur2, Elena M. Massarotti2, Bonnie L. Bermas3 and Karen H. Costenbader2, 1Rheumatology, Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 2Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 3Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

    Background/Purpose:  Prior studies suggest that cutaneous discoid lupus (DLE) is a marker for less severe disease with a low frequency of nephritis and end-stage renal…
  • Abstract Number: 1454 • 2012 ACR/ARHP Annual Meeting

    Characterization of Renal Mononuclear Phagocyte Populations in Murine SLE Nephritis

    Ranjit Sahu1, Ramalingam Bethunaickan2 and Anne Davidson1, 1Autoimmunity and Musculoskeletal Diseases, Feinstein Institute for Medical Research, Manhasset, NY, 2Autoimmunity, Feinstein Institute for Medical Research, Manhasset, NY

    Background/Purpose: Macrophages and dendritic cells contribute to renal damage in chronic renal diseases including lupus nephritis. However owing to their multiple phenotypic and functional variations,…
  • Abstract Number: 1445 • 2012 ACR/ARHP Annual Meeting

    Shared and Unique Molecular Features of Nephritis in 3 Models of Murine SLE

    Ramalingam Bethunaickan1, Celine C. Berthier2, Matthias Kretzler3 and Anne Davidson4, 1Autoimmunity, Feinstein Institute for Medical Research, Manhasset, NY, 2Nephrology, University of Michigan, Ann Arbor, MI, 3Internal Medicine, Division of Nephrology, University of Michigan, Ann Arbor, MI, 4Autoimmunity and Musculoskeletal Diseases, Feinstein Institute for Medical Research, Manhasset, NY

    Background/Purpose: Mouse models are useful for studying the pathogenesis of SLE nephritis but it is not clear which model is the most appropriate for understanding…
  • Abstract Number: 2239 • 2012 ACR/ARHP Annual Meeting

    Characterization of Pure Membranous Lupus Nephritis: A Cohort of 150 Patients

    Lucía Silva1, Teresa Oton1, Anca Askanase2, Patricia Carreira3, Francisco Javier López-Longo4, Anne Riveros5, Íñigo Rúa-Figueroa6, Javier Narvaez7, Esther Ruiz-Lucea8, Mariano Andres9, Enrique Calvo10, Francisco Toyos11, Juan J. Alegre12, Eva Tomero13, Carlos Montilla14, Antonio Zea15, Esther Uriarte-Isacelaya16, Jaime Calvo-Alen17, Carlos Marras18, Víctor M. Martínez-Taboada19, María Ángeles Belmonte20, Jose Rosas21, Enrique Raya22, Gema Bonilla23 and Mercedes Freire24, 1Rheumatology, Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda (Madrid), Spain, 2NYU School of Medicine, New York, NY, 3Rheumatology, Hospital Universitario 12 de Octubre, Madrid, Spain, 4Hospital General Universitario Gregorio Marañón, Department of Rheumatology, Madrid, Spain, 5Rheumatology, Hospital Universitario Germans Trias i Pujol, Badalona, Spain, 6Rheumatology, Hospital Universitario Dr Negrín. Las Palmas, Las Palmas de Gran Canaria, Spain, 7Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain, 8Rheumatology, Hospital de Basurto, Bilbao, Spain, 9Seccion Reumatologia, Hospital General Universitario de Alicante, Alicante, Spain, 10Rheumatology, Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Spain, 11Rheumatology, Hospital Universitario Virgen Macarena, Sevilla, Spain, 12Rheumatology, Hospital Universitario Dr Peset, Valencia, Spain, 13Rheumatology, Hospital Universitario de La Princesa. IIS La Princesa, Madrid, Spain, 14Unit Rheumatology, Hospital Universitario de Salamanca, Salamanca, Spain, 15Rheumatology, Hospital Universitario Ramon y Cajal, Madrid, Spain, 16Rheumatology, Hospital Universitario de Donostia, Donosti, Spain, 17Rheumatology, Hospital Sierrallana. Torrelavega, Torrelavega, Spain, 18Rheumatology, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain, 19Rheumatology, Hospital Universitario Marqués de Valdecilla. IFIMAV, Santander, Spain, 20Rheumatology, Hospital Universitario Carlos Haya, Málaga, Spain, 21Rheumatology, Hospital Marina Baixa. Villajoyosa, Villajoyosa, Spain, 22Rheumatology, University Hospital San Cecilio, Granada, Spain, 23Rheumatology, Hospital La Paz, Madrid, Spain, 24Rheumatology, Hospital Universitario Juan Canalejo, La Coruña, Spain

    Background/Purpose : Over 50% of patients with SLE develop renal involvement but only 20% of these are found to have pure membranous lupus neprhitis (MLN)…
  • « Previous Page
  • 1
  • 2
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences